Accelerated Atomic Particles for Diverse Applications

Publication ID: 24-11857808_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Accelerated Atomic Particles for Diverse Applications,” Published Technical Disclosure No. 24-11857808_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857808_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,808.

Summary of the Inventive Concept

This inventive concept leverages the core technology of particle therapy to treat cardiac arrhythmias and applies it to new industries and use cases, including neurological disorders, precision agriculture, non-invasive cancer diagnosis, advanced materials synthesis, and environmental remediation.

Background and Problem Solved

The original patent addressed the challenge of delivering accelerated atomic particles to targeted tissues in the heart, despite tissue movement. However, this technology has the potential to be applied to other fields, where precision and control are crucial. The new claims overcome the limitations of the original patent by expanding the scope of applications, enabling innovative solutions in diverse industries.

Detailed Description of the Inventive Concept

The inventive concept comprises a particle accelerator, gating module, and contouring module. The particle accelerator delivers accelerated atomic particles to a targeted area. The gating module synchronizes the particle delivery with specific patterns or cycles, ensuring precise control. The contouring module identifies and targets specific features or structures. The system can be adapted to various applications, such as treating neurological disorders, selectively sterilizing or mutating plant species, diagnosing cancer, synthesizing novel materials, and remediating environmental pollutants.

Novelty and Inventive Step

The new claims introduce novel applications and use cases that were not contemplated in the original patent. The inventive step lies in the recognition of the core technology's potential to be adapted to diverse fields, and the development of specific components and modules to address the unique challenges of each application.

Alternative Embodiments and Variations

Alternative embodiments may include variations in particle accelerator design, gating module synchronization algorithms, and contouring module feature recognition techniques. Additionally, the system could be integrated with other technologies, such as AI-assisted targeting or real-time imaging, to further enhance its capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across multiple industries, including healthcare, agriculture, materials science, and environmental remediation. The market for these applications is substantial, with potential customers including hospitals, research institutions, agricultural companies, and environmental organizations.

Field of Art

Particle therapy and targeted atomic particle delivery systems, encompassing medical treatment, materials science, and precision engineering technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in physics, biomedical engineering, or materials science, possessing expertise in particle acceleration, targeting systems, and interdisciplinary technology adaptation

Obviousness Rationale

A PHOSITA would recognize the fundamental principles of particle targeting and acceleration disclosed in the source patent as readily adaptable to multiple technical domains. The core technological components of particle acceleration, gating, and contouring represent transferable engineering principles that can be systematically applied across different fields. The variations in the PTD represent predictable extensions of the source patent's core technological framework by applying known particle delivery techniques to alternative problem domains.

Obvious Combinations & Variations

Source Patent Element
Mapping targeted tissue to compensate for physiological movements using gating and phase contouring
PTD Variation
Applying the same mapping and gating principles to neurological disorder treatment and cancer diagnosis
Obviousness Reasoning
A PHOSITA would recognize that tissue movement compensation techniques are universally applicable across biological systems, representing a known technique for precise particle targeting
Source Patent Element
Accelerated atomic particle delivery method for targeting specific tissue structures
PTD Variation
Extending particle delivery to materials synthesis and environmental remediation applications
Obviousness Reasoning
The fundamental particle acceleration and targeting mechanisms remain consistent across different material interactions, representing a predictable technological transfer
Source Patent Element
Precise synchronization of particle delivery with physiological cycles
PTD Variation
Adapting synchronization techniques to agricultural mutation and material modification processes
Obviousness Reasoning
Timing and synchronization represent fundamental engineering control principles that can be systematically adapted across technological domains
Source Patent Element
Contouring module for identifying critical targets within tissue
PTD Variation
Applying feature recognition techniques to identify pollutant structures or plant genetic features
Obviousness Reasoning
Feature recognition and targeting algorithms represent generalizable technological approaches that can be transferred between different detection and intervention contexts
Source Patent Element
Particle acceleration for medical intervention
PTD Variation
Repurposing particle acceleration for non-medical technological interventions
Obviousness Reasoning
Interdisciplinary technology transfer represents a standard engineering approach for expanding technological capabilities beyond original design constraints
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857808, a person having ordinary skill in the art would find the variations disclosed in this publication to represent obvious extensions of known particle targeting and acceleration technologies. The systematic application of core technological principles across diverse domains demonstrates that the claimed variations would have been obvious to a skilled practitioner at the time of invention, thereby establishing this publication as prior art capable of rendering subsequent similar claims obvious.

Original Patent Information

Patent NumberUS 11,857,808
TitleSystem and method for carbon particle therapy for treatment of cardiac arrhythmias and other diseases
Assignee(s)Mayo Foundation for Medical Education and Research